Peptides

Showing 37–48 of 54 results

• 
  API

  Retatrutide

  CAS:2381089-83-2

  Status:R&D

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Rusfertide

  CAS:1628323-80-7

  Status:R&D

  Indications:Diseases of blood and hematopoietic organs
• 
  API

  Semaglutide (Chemical synthesis)

  CAS:910463-68-2

  Status:DMF, WC

  Indications:Endocrine, nutritional, and metabolic disease
• 
  API

  Semaglutide (Semi-Recombinant)

  CAS:910463-68-2

  Status:DMF, WC

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Semaglutide(for Injectable)

  CAS:910463-68-2

• 
  API

  Semaglutide(for oral)

  CAS:910463-68-2

• 
  API

  Sermelanotide

  CAS:920014-72-8

  Status:R&D

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Somatostatin

  CAS:51110-01-1

  Status:CEP, NMPA, WC

  Indications:Digestive System Diseases
• 
  API

  Survodutide

  CAS:2805997-46-8

  Status:R&D

  Indications:Diseases of the circulatory system
• 
  API

  Teriparatide

  CAS:99294-94-7

  Status:DMF, NMPA

  Indications:Musculoskeletal system and connective tissue diseases
• 
  API

  Terlipressin

  CAS:14636-12-5

  Status:CEP, NMPA, WC

  Indications:Diseases of the digestive system and diseases of the urogenital system
• 
  API

  Thymalfasin

  CAS:69521-94-4

  Status:NMPA

  Indications:Certain infectious and parasitic diseases